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INTRODUCTION 
Praziquantel (PZQ) is the drug of choice for treatment of 
parasitic infections by trematodes or cestodes. Since the para­
sitic infections are common in many countries, PZQ is widely 
used. It is estimated that about one hundred million people 
take PZQ over the world every year. PZQ is safe enough for the 
global use even though it has some known adverse effects, such 
as abdominal pain, diarrhea, sleep disorder, dizziness, and head­
ache. These adverse effects are common but mild and transient, 
and require no specific medical intervention [1]. 
In addition to the common adverse effects, rather severe re­
actions to PZQ have been recognized. The severe reactions are 
drug eruptions, including skin rash or urticaria, dyspnea, and 
hypotensive shock. They are serious to require specific medical 
care. These serious symptoms or signs are induced by hypersen­
sitive or anaphylactic reaction of individuals to most of drugs. 
At present, 4 cases of PZQ hypersensitive reactions have been 
reported worldwide [2­5]. 
The hypersensitivity reaction is rare but serious when it oc­
curs. The present case report describes clinical findings of a clo­
norchiasis patient who had hypersensitive reactions after PZQ 
ingestion in Korea. 
CASE REPORT 
The patient was a 54­year­old­female who was running a 
dairy farm in Gyeongju, Korea. She had eaten raw trout a few 
times and cooked freshwater fish frequently but not enjoyed 
eating raw freshwater fish. She was found to pass eggs of Clo-
norchis sinensis through her feces when she was examined by a 
program of parasitic infection survey for dairy farmers in 2009. 
She was recommended to take PZQ with a dosage of 25 mg/kg 
×3. On 25 August, 2010, she took the first dose of PZQ (Dis­
tocide®, Shin Poong Pharmaceutical Co. Ltd., Seoul, Korea), 
and felt an itching sensation and noticed skin rashes on her 
hands and then on her entire body about 2 hr after the inges­
tion. She realized other symptoms of facial flushing, nausea, 
and dyspnea as well. The rashes ranged in their diameter from 
3 to 10 mm. The patient assumed that these symptoms had 
been caused by some kinds of food and the symptoms subsid­
ed during sleeping. She took the second dose of PZQ on the 
next day after eating breakfast. After the second ingestion, she 
experienced the same symptoms. She realized that PZQ might 
have caused the skin rash, and visited a local clinic. According 
ISSN (Print)  0023-4001
ISSN (Online)  1738-0006
Korean J Parasitol Vol. 49, No. 3: 273-275, September 2011   
http://dx.doi.org/10.3347/kjp.2011.49.3.273 ▣CASE REPORT




2 and Sung-Tae Hong
1,*
1Department of Parasitology and Tropical Medicine, and Institute of Endemic Diseases, Medical Research Center, Seoul National University College 
of Medicine, Seoul 110-799; Korea; 
2Department of Preventive Medicine, Dongguk University College of Medicine, Gyeongju 780-714, Korea 
Abstract: Praziquantel is the drug of choice for clonorchiasis. Since clonorchiasis is endemic in most river basins, prazi­
quantel has been widely used for 30 years in Korea. A 54­year­old Korean woman suffered from hypersensitive reactions, 
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to the record of the local clinic, the symptoms slightly subsid­
ed compared from the beginning but body itching and skin 
rashes persisted. Blood pressure was 116/64 with heart rate 64, 
and she was diagnosed as acute gastritis with Distocide® aller­
gy. The doctor prescribed chlorpheniramine maleate 0.5 am­
ple (anti­histamine) followed by bepotastine besilate 10 mg 
(second generation anti­histamine), methylprednisolone 4 
mg, and metoclopramide HCl 3.84 mg for 2 days. The symp­
toms disappeared after a few hours. At 14:30 she took 1 dose 
of PZQ with the prescribed medicines. After 2 hr, similar reac­
tions of mild degree appeared again. Itching and skin rashes 
were present but dyspnea was not. She consulted her medical 
problems with Prof. Lim and was recommended to stop tak­
ing PZQ. 
She had no specific medical history. She had been healthy 
without any experience of drug eruptions. She denied taking 
any other drugs simultaneously. 
She was examined of her feces at Department of Parasitolo­
gy and Tropical Medicine, Seoul National University. Her feces 
were confirmed to pass a few eggs of C. sinensis on 9 Septem­
ber, 2010. She was treated with flubendazole (Zelcom®, Chong 
Kun Dang Pharm. Seoul, Korea) 400 mg/day for 14 days as a 
substitute. Her feces were re­examined and no eggs were found 
in April 2011. 
DISCUSSION 
The present case demonstrated skin rashes and other symp­
toms of nausea, dizziness, and dyspnea after PZQ ingestion, 
which were compatible with those by hypersensitive reactions. 
She recognized the same drug reactions repeatedly after inges­
tion of PZQ. Therefore, it is evident that the present case had 
hypersensitive reactions to PZQ. 
Both PZQ and parasites are foreign bodies and become po­
tential allergens for a human body. In schistosomiasis, dead 
parasite bodies and eggs were recognized to induce the hyper­
sensitive reaction after PZQ medication [6]. PZQ kills S. japon-
icum in the blood vessel, and the disintegrated dead worms 
may suddenly release much amount of allergens into the blood. 
The suddenly increased allergens should trigger the anaphylac­
tic reaction after PZQ medication. Nonetheless, the present 
case is regarded as a patient of hypersensitive reaction which 
was induced by PZQ itself. There is only one recorded case of 
PZQ anaphylaxis in clonorchiasis [3]. That was a case of reac­
tion to PZQ not to the worms.
Since C. sinensis live in the intrahepatic bile duct, PZQ which 
is metabolized in the liver and excreted into the bile can kill 
the worms [7]. Since Tmax of PZQ is 2 hr after ingestion in hu­
mans, it takes more time than 2 hr to kill the worms [7]. Fur­
thermore, C. sinensis live in the bile duct and pass down to the 
intestine through the bile duct lumen after paralysis or death 
of worms by PZQ [8]. Since most of the dead worms of C. si-
nensis are discharged from the body, they have little chance of 
allergic stimulation within 2 hr after PZQ medication. Con­
trary to this, allergens from the dead worms of Schistosoma or 
Paragonimus are directly exposed to immune cells in the blood 
or tissue [2,6]. In this context, it is evident that the present case 
showed hypersensitive reactions to PZQ not to the parasite.
The hypersensitive or allergic reaction requires a primary 
sensitization to the allergen. It is uncertain when the present 
case had been previously exposed to PZQ. Although she de­
nied ingestion of the PZQ before, she had been exposed to PZQ 
in an unnoticed occasion. 
Since the present case was unable to finish whole dosage of 
PZQ therapy, she was examined and found still positive for C. 
sinensis eggs. She took flubendazole for 2 weeks, and became 
egg negative. Recently a hypersensitive case to PZQ has been 
reported in pulmonary paragonimiasis [2]. The case was treat­
ed with PZQ after desensitization. Desensitization is a good 
choice for cure of those hypersensitive or allergic patients of a 
certain drug. 
The cases of hypersensitive reaction to PZQ may have oc­
curred more than reported. Most cases of mild reactions have 
recovered without specific medical care. They have been unno­
ticed by physicians and therefore not reported. Only the cases 
of serious reactions have been selectively reported. There have 
been only 4 reported cases as hypersensitive or anaphylactic 
reaction to PZQ although it has been globally used for more 
than a billion people during the last 30 years.
In conclusion, PZQ is a safe anti­helminthic but hypersensi­
tive reaction may rarely occur. This is the 5th case of hypersen­
sitive reaction to PZQ as literature concerned.
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